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Abstract
Background: Wound healing is a highly dynamic process that requires signaling from the extracellular matrix to the
fibroblasts for migration and proliferation, and closure of the wound. This rate of wound closure is impaired in diabetes,
which may be due to the increased levels of the precursor for advanced glycation end products, 3-deoxyglucosone (3DG).
Previous studies suggest a differential role for p38 mitogen-activated kinase (MAPK) during wound healing; whereby, p38
MAPK acts as a growth kinase during normal wound healing, but acts as a stress kinase during diabetic wound repair.
Therefore, we investigated the signaling cross-talk by which p38 MAPK mediates wound healing in fibroblasts cultured on
native collagen and 3DG-collagen.
Methodology/Principal Findings: Using human dermal fibroblasts cultured on 3DG-collagen as a model of diabetic
wounds, we demonstrated that p38 MAPK can promote either cell growth or cell death, and this was dependent on the
activation of AKT and ERK1/2. Wound closure on native collagen was dependent on p38 MAPK phosphorylation of AKT and
ERK1/2. Furthermore, proliferation and collagen production in fibroblasts cultured on native collagen was dependent on
p38 MAPK regulation of AKT and ERK1/2. In contrast, 3DG-collagen decreased fibroblast migration, proliferation, and
collagen expression through ERK1/2 and AKT downregulation via p38 MAPK.
Conclusions/Significance: Taken together, the present study shows that p38 MAPK is a key signaling molecule that plays a
significantly opposite role during times of cellular growth and cellular stress, which may account for the differing rates of
wound closure seen in diabetic populations.
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Introduction
The wound healing process is a complex series of events that is
characterized by several phases including inflammation, prolifer-
ation, and remodeling [1,2]. One of the most important events in
wound repair is the migration and proliferation of dermal
fibroblasts resulting in wound closure. Infiltration of fibroblasts
allows for the remodeling of the extracellular matrix (ECM) and
retraction of the wound edges [1,2]. Chronic cutaneous wounds
which fail to heal within an expected time period are characterized
by impaired fibroblast proliferation and migration within the
wound area [1,3,4]. Impaired wound healing is a well-documented
phenomenon in diabetes. Studies have shown that the hypergly-
cemic state in diabetes is accompanied by impaired wound repair
as seen with decreased cellular migration and proliferation and
decreased collagen production and matrix formation
[1,3,4,5,6,7,8]. One possible reason for the defective wound
healing capacity observed in diabetes could be the presence of the
advanced glycation end product precursor 3-deoxyglucosone
(3DG). We previously demonstrated that 3DG-modified collagen
reduced fibroblast migration [9], proliferation, and ECM
production [10] while increasing apoptosis through the activation
of p38 mitogen activated protein kinase (MAPK) [11].
Many cytokines and growth factors transduce their signals via
activation of various kinase pathways. Among these are the growth
activated protein kinases including extracellular signal-regulated
protein kinase (ERK), the protein kinase B (PKB/AKT), and the
stress-activated protein kinase p38 MAPK. Both ERK and AKT
play an important role in signaling during cell proliferation, while
p38 MAPK has been classically associated with apoptosis and
cellular stress [12,13,14,15,16,17,18]. Recent studies have begun
to show an important role for p38 MAPK in cellular migration
and proliferation [14,19,20,21,22,23,24]. In dermal fibroblasts,
phosphorylation of p38 MAPK was found along the wound edge
and correlated with cell migration into the wound [20]. Chemical
inhibition of p38 MAPK resulted in decreased migration and
increased apoptosis of wounded dermal fibroblasts suggesting p38
MAPK plays a positive role in regulating wound healing [20,25].
Furthermore, pharmacological inhibition of p38 MAPK with
SB202190 resulted in cell death under normal growing conditions
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isoform of p38 MAPK, while the p38a isoform was found to
contribute to this cell death [26]. Despite the recent studies
suggesting a growth stimulating role for p38 MAPK, a majority of
the studies performed on p38 MAPK have attributed this kinase to
cell stress and reduced proliferation. In support of this, we have
shown that inhibition of p38 MAPK resulted in caspase-3
activation in dermal fibroblast cultured on native collagen, while
it inhibited 3DG-collagen-induced caspase-3 activity [11]. This
dichotomy suggests that p38 MAPK can be activated to signal as
either a growth kinase or a stress kinase which is dependent upon
extracellular stimuli.
The benefits of p38 MAPK signaling in wound healing is
controversial. During normal wound healing, activation of p38
MAPK results in complete wound closure while in chronic
diabetic wounds, p38 MAPK signaling results in aberrant wound
repair [1,8,15,20,22,24,25,27,28]. One reason for this dichotomy
could be the differential regulation of p38 MAPK during both
normal and diabetic wound repair. Currently there is no known
mechanism by which 3DG-collagen reduces proliferation and
migration of dermal fibroblasts; therefore, it is important to
understand the role of p38 MAPK during wound repair on 3DG-
collagen. In the present study we examined the role of p38 MAPK
signaling in dermal fibroblasts cultured on both native collagen
and 3DG-collagen to address the role of this kinase in the
regulation of wound healing.
Results
p38 MAPK differentially regulates the phosphorylation of
ERK1/2 and AKT
Previous studies within our laboratory have shown that 3DG-
collagen can induce a sustained increase in the phosphorylation of
p38 MAPK at 24 h [11]. Sustained p38 MAPK activity is
responsible for much of the stress-induced apoptosis observed in
cells, while low and transient phosphorylation of p38 MAPK is
associated with cell proliferation and migration. Studies have
shown that p38 MAPK can cross-talk with other pro-survival
kinases, including ERK1/2 and AKT [14,19,29,30]. During cell
proliferation and migration, p38 MAPK, ERK1/2, and AKT are
simultaneously upregulated [14,19,21]. However, during cellular
stress, p38 MAPK activation correlates with reduced phosphor-
ylation of ERK1/2 and AKT resulting in decreased proliferation
and migration of the cell and increased apoptosis [16,29,31,32].
Therefore, we investigated if 3DG-collagen-induced p38 MAPK
signaling modulates the phosphorylation of ERK1/2 and AKT.
Fibroblasts were pretreated with SB202190 (p38 MAPK inhibitor)
or the vehicle DMSO for 1 h and then cultured on native collagen
or 3DG-collagen for 24 h. Phosphorylation of p38 MAPK,
ERK1/2, and AKT was detected by Western blotting. Confirming
our previously published data [11], phosphorylation of p38
MAPK was increased by 75%64.1% when fibroblasts were
grown on 3DG-collagen compared to those cultured on native
collagen (Figure 1A). Inhibition of p38 MAPK with SB202190 in
fibroblasts cultured on 3DG-collagen increased the expression of
phospho-ERK1/2 from 48%612% to 93%65.8% (Figure 1B,
p,0.01). Likewise we observed that phospho-AKT increased from
48%63.7% in cells cultured on 3DG-collagen to 101%69.5% in
fibroblasts cultured on 3DG-collagen with the inhibitor SB202190
(Figure 1B, p,0.01). However, in fibroblasts cultured on native
collagen, we observed that inhibition of p38 MAPK downregu-
lated phospho-ERK1/2 to 53%612% and phospho-AKT to
52%612.7% (Figure 1B, p,0.01) suggesting 3DG-collagen
changes the cross-talk between p38 MAPK, ERK1/2, and
AKT. These results also suggest that p38 MAPK in the presence
of native collagen can act as a growth kinase promoting the
phosphorylation of both ERK1/2 and AKT. However, the
signaling in fibroblasts cultured on 3DG-collagen altered p38
MAPK to act as a stress kinase resulting in the depression of
ERK1/2 and AKT phosphorylation.
Figure 1. p38 MAPK differentially regulates ERK1/2 and AKT
phosphorylation. 70% confluent fibroblasts were pretreated with
SB202190 or vehicle DMSO for 1 h and cultured on native collagen or
3DG-collagen for 24 h. Expression of phospho-p38 MAPK (A), and
phopsho-ERK1/2 and phospho-AKT, (B) were analyzed by Western blot
using whole cell lysates. Total p38 MAPK, total ERK1/2, and total AKT
served as loading controls. The bars correspond to the densitometric
values of the intensity of both phospho-ERK1/2 bands and the
phospho-AKT band compared to that of total ERK1/2 (both bands)
and AKT band within each sample, respectively. The density of each
sample was then made relative to the density observed in cells cultured
on native collagen. All comparisons were made against their respective
controls corresponding to native collagen treated with DMSO or 3DG-
collagen treated with DMSO. Data are mean 6 SD (n=3), *P,0.01.
doi:10.1371/journal.pone.0018676.g001
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fibroblasts cultured on 3DG-collagen or native collagen
We previously demonstrated that 3DG-collagen downregulated
the migration of dermal fibroblasts in an in vitro wound site [9].
Since we observed that the inhibition of p38 MAPK in fibroblasts
cultured on 3DG-collagen restored the level of phospho-ERK1/2
and phospho-AKT to levels observed in fibroblasts cultured on
native collagen, and the phosphorylation of these proteins are
known to promote the growth and migration of fibroblasts; we
sought to evaluate the significance of p38 MAPK on fibroblast
migration. Utilizing an in vitro scratch assay, confluent fibroblasts
were pretreated with DMSO, SB202190 (p38 MAPK inhibitor),
PD98059 (ERK1/2 inhibitor), or LY294002 (AKT inhibitor) for
1 h and a scratch was made along the monolayer of cells. The cells
were cultured with the inhibitors for an additional 24 h or 48 h.
Fibroblasts cultured on native collagen in the absence of any of the
inhibitors had closed the wound by 95%61.0% by 48 h, while
fibroblasts cultured on 3DG-collagen had closed the wound by
68%62.6% (Figure 2, p,0.001). In the presence of the p38
MAPK inhibitor SB202190, fibroblasts cultured on native
collagen were unable to efficiently migrate into the wound,
resulting in only 67%63.5% closure by 48 h, the same as that
observed in fibroblasts cultured on 3DG-collagen (Figure 2,
p,0.001). However, inhibition of p38 MAPK in fibroblasts
cultured on 3DG-collagen restored the migration of fibroblasts,
closing the wound by 88%62.2% in 48 h (Figure 2, p,0.001).
These results suggest that p38 MAPK may be acting as a stress
kinase in the presence of 3DG-collagen resulting in decreased
migration, while p38 MAPK may act as a growth response kinase
in fibroblasts cultured on native collagen allowing for fibroblast
migration and closure of the wound.
To further investigate how p38 MAPK may be altering cellular
migration, we investigated the growth kinases ERK1/2 and AKT,
which are known to regulate wound closure. Fibroblasts pretreated
with the ERK1/2 inhibitor PD98059 and cultured on either
native collagen or 3DG-collagen did not alter the rate of wound
closure compared to that seen in their respective control groups
(Figure 2). Moreover, inhibition of both ERK1/2 and p38 MAPK
resulted in wound closure rates similar to that seen in fibroblasts
pretreated with only the p38 MAPK inhibitor, therefore wound
closure is not significantly dependent on ERK1/2 activation.
Pretreatment of fibroblasts cultured on native collagen with the
AKT inhibitor LY294002, closed the wound by only 66%64.0%
in 48 h (p,0.001), and the addition of LY294002 to fibroblasts
cultured on 3DG-collagen resulted in a significant further
reduction in cell migration, as only 6.7%62.1% of the wound
was closed in 48 h (Figure 2, p,0.0001). The addition of the p38
MAPK inhibitor SB202190 did not further alter the wound
closure rates of fibroblasts cultured on native collagen
(66%64.0%) suggesting that p38 MAPK dependent activation
of AKT controls migration along native collagen. In contrast, p38
MAPK and AKT inhibition showed a partial upregulation in
wound closure compared to AKT inhibition alone in fibroblasts
cultured on 3DG-collagen (30%62.2%) suggesting that p38
MAPK regulation of wound closure is primarily dependent upon
the activation of AKT, however in the absence of both p38 MAPK
and AKT, activation of ERK1/2 or other survival kinases may
help promote migration (Figure 2). Furthermore we did not see
any change in the phosphorylation of p38 MAPK after the use of
the ERK and AKT inhibitors suggesting these inhibitors only
affected the their own kinase activity and not that of p38 MAPK
(data not shown). These results suggest that regulation of wound
healing is dependent on p38 MAPK.
One of the main migratory features of dermal fibroblasts is the
extension of their filopodia along the collagen matrix [33,34,35].
After mechanical wounding, fibroblasts begin to extend their
filopodia into the wound site by 4 h [9,36]. We previously
demonstrated that 3DG-collagen caused reduced filopodia
extension [9]. Therefore, we investigated the effect of p38 MAPK
on filopodia extension of fibroblasts cultured on native collagen
and 3DG-collagen after mechanical wounding. Fibroblasts were
pretreated with the p38 MAPK inhibitor SB202190 and the
cultured on native collagen or 3DG-collagen until confluent. After
confluency, a scratch was made and the actin filaments were
stained using rhodamine phalloidin at 4 h post-scratch. As seen
previously [9], fibroblasts cultured on native collagen increased
their filopodia by 4 h. In contrast, fibroblasts grown on 3DG-
collagen showed minimal extension of their filopodia at 4 h
(Figure 3). Inhibition of p38 MAPK with SB202190 delayed
filopodia extension into the wound site when fibroblasts were
cultured on native collagen. However, inhibition of p38 MAPK
induced filopodia extension in fibroblasts cultured on 3DG-
collagen (Figure 3). These results suggest that when fibroblasts are
cultured on native collagen p38 MAPK is required for proper
filopodia extension, while upregulation of p38 MAPK in
fibroblasts grown on 3DG-collagen leads to inhibition of filopodia
extension. These results corroborate the current findings that p38
MAPK differentially regulates cellular migration, which is
dependent upon the dermal fibroblast’s interaction with extracel-
lular stimuli. Moreover, these results are consistent with the
findings that p38 MAPK reduces cell migration through
downregulation of the phosphorylation of AKT when fibroblasts
are cultured on 3DG-collagen as this kinase is needed for proper
migration and cell survival.
Fibroblast proliferation is dependent upon p38 MAPK
activation of AKT
AGE-modified collagen can reduce the proliferation of cells
[37,38] Both ERK1/2 and AKT are known kinases integrally
involved in cell proliferation [14,16,17,29,30,31]. Because p38
MAPK has been shown to inversely regulate the expression of
these kinases in both a stress and growth environment, we
investigated the role of p38 MAPK in cell proliferation. Fibroblasts
were pretreated with SB202190, LY294002, PD98059, or a
combination of the inhibitors and cultured on either native
collagen or 3DG-collagen. Cell proliferation was measured at 0 h,
24 h, and 48 h. Fibroblasts cultured on native collagen were found
to steadily proliferate over 48 h, while fibroblasts cultured on
3DG-collagen decreased their proliferative capacity by 48 h
(Figure 4, p,0.05). There was a downregulation in the rate of
proliferation when p38 MAPK was inhibited in fibroblasts
cultured on native collagen compared to control. When p38
MAPK was inhibited with SB202190 in fibroblasts cultured on
3DG-collagen, proliferation was restored (Figure 4, p,0.05) to
numbers similar to fibroblasts cultured on native collagen at 48 h.
Next we investigated which protein kinase p38 MAPK was
regulating to induce proliferation. Fibroblasts were pretreated with
the ERK1/2 inhibitor PD98059 or the AKT inhibitor LY294002
and proliferation was measured over 48 h. We found that the rate
of proliferation in fibroblasts cultured on native collagen was
dependent on AKT but not ERK1/2 as only inhibition of AKT
showed similar levels of proliferation to that seen in fibroblasts
pretreated with the p38 MAPK inhibitor (Figure 4, p,0.01).
Moreover, the simultaneous inhibition of p38 MAPK and AKT
did not provide any significant additive effect to the decreased rate
of proliferation seen in these fibroblasts, suggesting that prolifer-
ation is dependent on the p38 MAPK regulation of AKT (Figure 4,
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PLoS ONE | www.plosone.org 3 May 2011 | Volume 6 | Issue 5 | e18676p,0.01). In addition, fibroblasts pretreated with only the AKT
inhibitor for 1 h and then cultured on 3DG-collagen showed no
signs of proliferation in the first 24 h and by 48 h the majority of
the cells had died, while there was no significant change in the
proliferation capacity of these cells when ERK1/2 was inhibited
(Figure 4, p,0.01). These studies suggest that 3DG-collagen-
induced p38 MAPK downregulates cell proliferation by decreasing
phosphorylation of AKT.
AKT activation is required for regulation of caspase-3 by
p38 MAPK in fibroblasts cultured on native collagen and
3DG-collagen
ASK1 is able to phosphorylate p38 MAPKto signal the activation of
apoptotic cascade [15,27,39,40]. However, recent studies have shown
that H-ras-dependent upregulation of p38 MAPK can enhance cell
survival in cancer cells through activation of AKT [21,22,23,24].
Furthermore, we demonstrated that 3DG-collagen induced the
expression of caspase-3 [11]. Therefore, we investigated the role of
p38 MAPK in caspase-3 activation under growth and stress conditions.
When fibroblasts were pretreated with the p38 MAPK inhibitor
SB202190 and cultured on native collagen, there was a 81%65.5%
increase in the level of caspase-3 activation (Figure 5, p,0.001). To
determine how p38 MAPK is regulating caspase-3 activation in
fibroblasts cultured on native collagen we investigated the role of AKT
and ERK1/2. The regulation of caspase-3 by p38 MAPK in
fibroblasts cultured on native collagen was dependent on the activation
of AKT as inhibition of AKT increased the level of caspase-3 to
190%64.5%(p,0.001).Additionally,there wasno significant additive
Figure 2. Wound closure rates in fibroblasts pretreated kinase inhibitors. A. Confluent fibroblasts were pretreated with the inhibitors; p38
MAPK inhibitor SB202190, AKT inhibitor LY294002, or the ERK1/2 inhibitor PD98059 for 1 h and cultured on native collagen or 3DG-collagen. The
fibroblasts were then scratched manually with a pipette tip to introduce a wound as previously described. Cell migration into the wound was
monitored at 0 h, 24 h, and 48 h by bright field visualization with an epi-fluorescence microscope. For each sample the distance across the wound
margin was measured at 10 different points from wound edge to wound edge using Spot software. The measured distance was then converted into
a percentage of wound closure when compared to the initial scratch at 0 h as shown in Material and Methods. All statistical comparisons were
performed within each time point. Inhibitor comparisons were compared to their respective controls (native collagen or 3DG-collagen). B. To
determine that LY294002 or PD98059 did not affect p38 phosphorylation, we pretreated fibroblasts with the AKT or ERK inhibitors for 1 h and
cultured the cells on native collagen (COL) or 3DG-collagen (3DG) for 24 h. Whole cell lysates were extracted and phosphorylated p38 MAPK was
detected by Western blotting. Phosphorylation of p38 MAPK was normalized to total p38 MAPK. The blot shown is representative of two individual
experiments, each producing similar results. All statistical comparisons were performed within each time point. Inhibitor comparisons were compared
to their respective controls (native collagen or 3DG-collagen). Data are mean 6 SD (n=3), **P,0.0001, *P,0.001.
doi:10.1371/journal.pone.0018676.g002
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AKT were simultaneously inhibited (208%62.6%). Moreover, the
inhibition of ERK1/2 with PD98059 did not significantly increase the
expression of caspase-3 (109%63.2%), while inhibition of both
ERK1/2 and p38 MAPK increased the expression of caspase-3 to
187%67.0% (Figure 5, p,0.001). Survival of fibroblasts cultured on
native collagen is dependent upon p38 MAPK-induced AKT
activation.
Figure 3. Differential regulation of filopodia extension after fibroblast pretreatment with the p38 MAPK inhibitor SB202190.
Fibroblasts were pretreated for 1 h with the p38 MAPK inhibitor SB202190, or the vehicle DMSO and then cultured on native collagen or 3DG-
collagen until confluent. The monolayer of cells was then manually scratched with a pipette tip to introduce the wound. At 4 h post-scratch the
fibroblasts were fixed, permeabilized with Triton X-100, and stained with the F-actin dye rhodamine phalloidin. Extension was denoted as filopodia
protrusion from initial wound site. The dotted line denotes initial wound site taken at 20 X magnification. Inset picture taken at 40 X magnification.
Scale bar represents 10 mm.
doi:10.1371/journal.pone.0018676.g003
Figure 4. Proliferation rates in fibroblasts pretreated with kinase inhibitors. 4610
3 cells/well were pretreated with the p38 MAPK inhibitor
SB202190, AKT inhibitor LY294002, or ERK1/2 inhibitor PD98059 for 1 h and then seeded in a 96-well plate containing either native collagen or 3DG-
collagen for 0 h, 24 h, and 48 h. At each designated time point the level of proliferation was determined using the cell proliferation reagent WST-1.
Quantification of each sample was determined by measuring the absorbance at 450 nm, with a reference wavelength of 600 nm. Comparisons were
performed within each time point and compared to their respective controls (native collagen or 3DG-collagen). Data are mean 6 SD (n=3),
**P,0.01, *P,0.05.
doi:10.1371/journal.pone.0018676.g004
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cultured on 3DG-collagen. Fibroblasts cultured on 3DG-collagen
increased the expression of caspase-3 to 271%66.6% and this
upregulation was abrogated when p38 MAPK was inhibited
(Figure 5, 108%61.5%, p,0.0005). Also, p38 MAPK downreg-
ulated the phosphorylation of AKT and ERK1/2 in fibroblasts
cultured on 3DG-collagen (Figure 1); therefore, we investigated
whether downregulation of AKT or ERK1/2 by p38 MAPK was
responsible for increased caspase-3 activation in fibroblasts
cultured on 3DG-collagen. The activation of caspase-3 by p38
MAPK in fibroblasts cultured on 3DG-collagen was shown to be
dependent on the inactivation of AKT. Inhibition of AKT
(LY294002) caused a 190%65.0% increase in the level of caspase-
3 activation in fibroblasts cultured on 3DG-collagen (Figure 5).
This increase was not significantly altered when fibroblasts were
pretreated with both AKT and p38 MAPK inhibitors simulta-
neously (161%67.1% increase), unlike that seen in fibroblasts
treated simultaneously with ERK1/2 (PD98059) and p38 MAPK
(SB202190) inhibitors (172%66.8% increase with ERK1/2
inhibitor vs. 14%66.6% increase with ERK1/2 and p38 MAPK
inhibitor). These results suggest that in fibroblasts cultured on
3DG-collagen p38 MAPK reduces the phosphorylation of AKT,
which is responsible for increased caspase-3 activation.
Type I collagen expression is inversely regulated by p38
MAPK in fibroblasts cultured on native collagen and
3DG-collagen
During wound healing, type I collagen is synthesized by dermal
fibroblasts to aid in successful contraction of the wound margins
[1,2]. We previously demonstrated that 3DG-collagen inhibits the
expression of type I collagen in fibroblasts [10]; therefore, we
investigated the role of p38 MAPK in type I collagen production.
Fibroblasts were pretreated for 1 h with the inhibitors SB202190,
LY294002, PD98059, or a combination of inhibitors were cultured
on nativecollagen or3DG-collagen for 24 h.Fibroblasts cultured on
nativecollagen induced theexpressionofcollagen atboth the levelof
transcription and translation. In contrast, fibroblasts cultured on
3DG-collagen reduced both the transcript levels of COL1A1
(75%63.2%, Figure 6A) and the protein levels of procollagen
(71%63.6%, Figure 6B). Inhibition of p38 MAPK with SB202190
in fibroblasts cultured on native collagen showed both reduced
transcript levels of COL1A1 (68%63.2%, p,0.05) and reduced
expression of procollagen (62%66.5%, p,0.05, Figure 6). In
contrast, inhibition of p38 MAPK restored the expression of
COL1A1 (101%64.2%) and procollagen (98%64.4%) in fibro-
blasts grown on 3DG-collagen (Figure 6, p,0.05).
Moreover, p38 MAPK regulation of collagen was dependent on
the activation of both AKT and ERK1/2 as there was a similar
decrease in collagen expression when both p38 MAPK and AKT
and p38 MAPK and ERK1/2 were inhibited in fibroblasts grown
on native collagen (Figure 6, p,0.05). In fibroblasts cultured on
3DG-collagen, collagen expression was dependent on the p38
MAPK downregulation of both AKT and ERK1/2 as restoration
of collagen expression by p38 MAPK inhibition was abrogated
when both AKT and ERK1/2 were independently inhibited
(Figure 6, p,0.05). These data suggest that p38 MAPK is playing
a major role in the transcription and translation of collagen.
Furthermore, this data highlights that p38 MAPK is playing a
positive role in the regulation of collagen when fibroblasts are
grown on native collagen, while playing a negative role in
fibroblasts grown on 3DG-collagen.
Discussion
Cutaneous wound healing is a dynamic process that is regulated
by the balance of the pro-survival signaling pathway and the pro-
Figure 5. Caspase-3 activation after fibroblast pretreatment with kinase inhibitors. Fibroblasts were pretreated with the inhibitors; p38
MAPK inhibitor SB202190, AKT inhibitor LY294002, or ERK1/2 inhibitor PD98059 for 1 h and then cultured on native collagen or 3DG-collagen for
24 h. Whole cell lysates were assayed for caspase-3 activity at an absorbance of 405 nm. All comparisons were made against their respective controls
(native collagen or 3DG-collagen alone). Data are mean 6 SD (n=3), **P,0.0005, *P,0.001.
doi:10.1371/journal.pone.0018676.g005
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the dermal fibroblasts proliferate and migrate allowing for
contraction of the wound margins [2,4]. However, during times
of chronic wound repair as seen in diabetes, the dermal fibroblast
appears to be incapable of proper proliferation and migration
resulting in aberrant and delayed wound closure [3,4,5,6,7,8].
Moreover, there is an increase in the number of apoptotic cells
residing in chronic wounds, which would further decrease the
wound healing rate [6,7,8]. Recent evidence has provided a dual
role for the stress-activated kinase p38 MAPK in both normal and
chronic wound repair and our findings support this observation.
Under normal wound repair, studies have shown that p38 MAPK
can be activated to induce cell proliferation and migration; while
p38 MAPK has been shown to induce apoptosis and prevent cell
migration in chronic diabetic wounds [1,14,20,22,25,41,42]. In
support of this, increased levels of 3DG-collagen have been shown
to induce caspase-3 and reduce fibroblast migration [9,11];
however, the signaling mechanism by which 3DG-collagen may
impact diabetic wound healing had not been investigated. These
results suggest that p38 MAPK is being differentially regulated by
Figure 6. Expression of type I collagen after fibroblast pretreatment with kinase inhibitors. Fibroblasts were pretreated with p38 MAPK
inhibitor (SB202190), AKT inhibitor (LY294002), or ERK1/2 inhibitor (PD98059) for 1 h and then cultured on native collagen or 3DG-collagen for 24 h.
A, COL1A1 mRNA levels were quantified by real-time RT-PCR and transcripts were normalized to b-actin. B, The bar graph was obtained by
determining the expression levels of procollagen analyzed by Western blot and normalized to b-actin which was the loading control and the bars
correspond to the relative density of procollagen protein compared to that observed in cells cultured on native collagen treated with DMSO.
Statistical comparisons were also made against their respective controls (native collagen or 3DG-collagen). Data are mean 6 SD (n=3), *P,0.05.
doi:10.1371/journal.pone.0018676.g006
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normal wounds and chronic wounds, respectively. Because of the
antagonizing role p38 MAPK plays, we sought to better
understand how p38 MAPK signals to promote cell survival and
cell death in normal and chronic wounds.
In this study, we provide evidence for a novel mechanism by
which the differential regulation of p38 MAPK is dependent upon
the fibroblast’s interaction with varying extracellular stimuli. p38
MAPK can be regulated by both the growth factor induced-
GTPase H-ras and the pro-apoptotic kinase ASK1. Previous
studies have provided a fundamental role for H-ras-induced p38
MAPK signaling in promoting cell survival; while activation of
ASK1 induces p38 MAPK signaling to promote apoptosis
[15,22,23,24,27,30,43,44]. Further evidence has suggested that
the activation of H-ras can suppress the phosphorylation of ASK1
thereby preventing cell death and promoting proliferation and
migration of cells [45,46]. Through the use of pharmacological
inhibitors, we found that fibroblasts cultured on 3DG-collagen
have a sustained activation of p38 MAPK as evidenced by its
upregulation at 24 h (Figure 1). Studies have shown that sustained
activation of p38 MAPK is responsible for the increased apoptosis
and reduced cellular migration [16]. This effect is dependent on
the ability of p38 MAPK to be activated as a stress kinase by an
upstream mediator such as ASK1. Also, ASK1 has been shown to
induce p38 MAPK during times of cellular stress [39]. In contrast,
native collagen transiently phosphorylates p38 MAPK to promote
growth of the fibroblast, which suggests that under normal growth
conditions p38 MAPK may be phosphorylated by the upstream
mediator H-ras.
p38 MAPK cross-talks with other members of the MAPK
family, especially ERK1/2 and AKT [29,30]. Under normal
conditions, signaling within the fibroblast via p38 MAPK, ERK1/
2, and AKT results in proliferation and migration of the cell
[14,21]. However, under times of cellular stress, p38 MAPK may
inhibit the activation of ERK1/2 and AKT leading to the
upregulation of pro-apoptotic genes [16,31,32]. 3DG-collagen
induced changes in the signaling cross-talk between p38 MAPK
and ERK1/2 and AKT, as we observed that 3DG-collagen
decreased the phosphorylation of ERK1/2 and AKT, and this was
found to be dependent on p38 MAPK activation (Figure 1).
Additionally, inhibition of p38 MAPK in fibroblasts cultured on
native collagen reduced the phosphorylation of ERK1/2 and
AKT, which supports previous claims [14,17] that under normal
conditions p38 MAPK, ERK1/2, and AKT work synergistically to
enhance cell growth (Figure 1).
Downregulation of the ERK1/2 and AKT pathway can lead to
decreased migration and proliferation of the cell
[14,16,17,21,31,32,47]. Previous work in our laboratory has
demonstrated that 3DG-collagen decreased the proliferation and
migration of fibroblasts [9] suggesting that decreased phosphor-
ylation of ERK1/2 and AKT mediated via p38 MAPK activation
is responsible for this growth depression. Chemical inhibition of
p38 MAPK with SB202190 in fibroblasts grown on 3DG-collagen
restored the migration potential of these fibroblasts to that
observed in fibroblasts grown on native collagen (Figure 2). The
decreased migration seen in fibroblasts cultured on 3DG-collagen
was due to the p38 MAPK depression of phosphorylated AKT
(Figure 2). Also, p38 MAPK inhibition in fibroblasts grown on
native collagen reduced the migratory capacity of these cells,
supporting a dual role for the need of both p38 MAPK and AKT
activation in non-stressed cells (Figure 2). In support of this, the
AKT inhibitor did not affect the phosphorylation state of p38
MAPK suggesting that the p38 MAPK inhibitor can act on both
the activity of itself and that of AKT, while the AKT inhibitor can
only act by reducing AKT phosphorylation. Although inhibition of
ERK1/2 did not significantly alter the migration rate of
fibroblasts, we cannot rule out the possibility that ERK1/2 plays
a role in migration as AKT activation could mask the effects of
ERK1/2. Furthermore, simultaneous inhibition of both p38
MAPK and AKT in fibroblasts cultured on 3DG-collagen did
not result in reduced migration comparable to that seen when
AKT alone was blocked, suggesting that ERK1/2 activation is
playing a role in controlling fibroblast migration. This role
however, may be secondary to that of AKT.
During wound healing, fibroblasts along the wound edge begin
to extend their filopodia to promote migration into the wound. We
previously demonstrated that at 4 h post-wounding, fibroblasts
cultured on 3DG-collagen show minimal extension of their
filopodia into the wound [9], in contrast to the extension of
filopodia observed in fibroblasts cultured on native collagen.
Filopodia extension was restored in fibroblasts cultured on 3DG-
collagen when p38 MAPK was inhibited (Figure 3). Together
these results support the idea that p38 MAPK promotes cell
migration by upregulating AKT in fibroblasts cultured on native
collagen, while p38 MAPK acts as a stress kinase to depress
migration in fibroblasts cultured on 3DG-collagen.
Proliferation of fibroblasts also showed dependence of p38
MAPK induction of AKT. p38 MAPK-induced AKT activity
promoted cell proliferation in fibroblasts cultured on native
collagen (Figure 4). Moreover, 3DG-collagen reduced the
proliferation of fibroblasts, which was found to be dependent on
p38 MAPK suppression of AKT (Figure 4), which supports a dual
role for p38 MAPK controlling wound closure. Accompanying
reduced proliferation in fibroblasts cultured on 3DG-collagen was
an upregulation in caspase-3 activation. Caspase-3 is an early
marker of apoptosis, which can be activated by ASK1-induced
p38 MAPK. Upregulation of caspase-3 in fibroblasts cultured on
3DG-collagen was dependent on the p38 MAPK downregulation
of AKT (Figure 5). In contrast, p38 MAPK promoted cell survival
through phosphorylation of AKT in fibroblasts cultured on native
collagen (Figure 5). These results further suggest native collagen
promotes cell survival through activation of p38 MAPK, while
3DG-collagen results in caspase-3 activation through activation of
p38 MAPK. The final step in wound closure is the fibroblast’s
ability to remodel the ECM through production of type I collagen.
p38 MAPK promoted the production of collagen both transcrip-
tionally and translationally in fibroblasts cultured on native
collagen, which was found to be dependent on the activation of
AKT and ERK1/2 by p38 MAPK (Figure 6). In contrast,
activation of p38 MAPK reduced the production of collagen,
which was dependent on the downregulation of AKT and ERK1/
2, in fibroblasts cultured on 3DG-collagen (Figure 6). Because
there was an additive effect when both p38 MAPK and ERK or
AKT were inhibited, p38 MAPK, ERK, and AKT could be
working through independent but redundant pathways. Although
this claim is beyond the scope of this paper, it may be worth
investigating other upstream mediators that control p38 MAPK,
ERK, and AKT simultaneously such as TGF-beta, H-ras, and
ASK-1, which are known to be involved in wound healing. Wound
healing is a complex process that utilizes a network of signaling
pathways activated by different stimuli and can converge upon
multiple kinases to regulate gene expression, proliferation, and
survival of the cell. Because both H-ras and ASK1 have been
shown to activate p38 MAPK during times of growth and stress,
respectively, we anticipate that H-ras mediates the phosphoryla-
tion of p38 MAPK to promote migration and proliferation of the
fibroblast, while ASK1 phosphorylates p38 MAPK to activate
downstream stress responses.
Differential Regulation of p38 MAPK
PLoS ONE | www.plosone.org 8 May 2011 | Volume 6 | Issue 5 | e18676The antagonizing roles of p38 MAPK in wound healing have
not been extensively elucidated. Furthermore, the signaling cross-
talk among p38 MAPK and other kinases such as AKT and
ERK1/2 have not been fully investigated in dermal fibroblasts
cultured on both native collagen and 3DG-collagen. Here we
report that under normal wound healing conditions p38 MAPK
promotes the closure of the wound through increased fibroblast
migration, proliferation, and collagen production. Activation of
p38 MAPK as a growth kinase resulted in upregulation of AKT
and ERK1/2 which were essential for proliferation and migration
of fibroblasts on native collagen (Figure 7). In contrast, fibroblasts
cultured on 3DG-collagen, decreased wound closure similar to
that seen in chronic diabetic wounds (Figure 7). p38 MAPK has
been implicated as a stress kinase in chronic wounds, which results
in decreased proliferation and migration and increased apoptosis
of fibroblasts [42]. Although these studies relied heavily upon the
use of pharmacological inhibitors, we did not notice any change in
the phosphorylation of p38 MAPK following the use of AKT and
ERK inhibitors (Figure 2B). However, it should be noted that
other non-specific off target effects may have taken place and
future studies should also include siRNA against p38 MAPK to
validate these claims. Despite the reliance on pharmacological
inhibitors, the data presented does corroborate the different roles
that p38 MAPK has been shown to play during times of stress and
growth.
Regulation of p38 MAPK activation appears to be critical
during wound healing. This apparent dichotomy between normal
and chronic wound healing associated with p38 MAPK suggests
that extracellular stress on the fibroblast can alter the signaling
cross-talk associated with cell survival to promote pro-apoptotic
events. More importantly, this is the first evidence providing a
mechanism by which 3DG-modified collagen, which is upregu-
lated in diabetic wounds, prevents in vitro wound closure through
the dysregulation of p38 MAPK. These results may have bearing
on current therapeutic strategies for treating wounds in diabetic
patients.
Materials and Methods
This study was approved by the Internal Review Board of
Drexel University for human studies.
Tissue Culture
Collagen coating of culture dishes with cross linking of the
collagen has been described previously [9,11]. Normal human
dermal fibroblasts from individuals (GM08333, GM00498,
GM04190, GM00321) aged 3-85years old (passage ,10) were
purchased from the Coriel Institute (Camden, NJ). Fibroblasts
were seeded onto native collagen and 3DG-collagen coated dishes
and cultured until 70% confluent in Dulbecco’s Modified Eagle’s
Medium (DMEM) supplemented with 10% dialyzed FBS and 1%
penicillin/streptomycin unless otherwise noted.
Chemicals and Antibodies
p38 MAPK inhibitor SB202190 was purchased from Sigma (St.
Louis, MO). AKT inhibitor LY294002, ERK1/2 inhibitor
PD98059, and monoclonal antibody against type I collagen (sc-
133179) was purchased from Santa Cruz Biotechnology (Santa
Cruz, CA). Polyclonal antibodies against phospho-p38 MAPK,
phospho-ERK1/2, phospho-AKT, total p38 MAPK, total ERK1/
2, total AKT, and b-actin were purchased from Cell Signaling
Technologies (Danvers, MA). Secondary antibodies were pur-
chased from Jackson Labs (West Grove, PA).
Inhibition of p38 MAPK, ERK1/2, and AKT
For inhibition studies, fibroblasts were cultured until 70%
confluent, trypsinized, preincubated for 1 h with or without the
p38 MAPK inhibitor SB202190 (10 mM), ERK1/2 inhibitor
PD98059 (50 mM), or AKT inhibitor LY294002 (25 mM), and
then replated onto collagen or 3DG-collagen coated dishes for
24 h in DMEM containing 1% FBS and 1% Pen/Strep. The
concentrations of inhibitors are similar to doses used in previously
published studies [19,23,48].
SYBR Green Quantitative RT-PCR
Cells were harvested and RNA was extracted using the RNeasy
Mini kit (Qiagen, Valencia, CA) according to manufacturer’s
protocol. To verify expression of COL1A1; 2.0 mg of total RNA
was reverse-transcribed using Superscript-III reverse transcriptase
(Invitrogen Carlsbad, CA), according to manufacturer’s protocol.
Transcripts were quantified using SYBR green PCR amplification
(Qiagen). All mRNA transcripts were normalized to b-actin
expression. The following primers were employed to detect
transcripts of interest: COL1A1-forward: 59-CCAGAAGAAC-
TGGTACATCAGCA-39 and COL1A1-reverse: 59-CGCCATA-
CTCGAACTGGAAT-39; b-actin-forward 59-TTGCCGACAG-
GATGCAGAA-39 and b-actin-reverse 59-GCCGATCCACACG-
GAGTACTT-39.
Figure 7. Diagram of p38 MAPK regulation of wound healing
on native collagen and 3DG-collagen. Under normal wound
healing phosphorylation of p38 MAPK activates AKT and ERK1/2 to
promote migration, proliferation, and collagen production. During
diabetic wound healing, 3DG-collagen negatively impacts the dermal
fibroblast by phosphorylating p38 MAPK to downregulate the
expression of ERK1/2 and AKT and promote reduced cell proliferation
and migration.
doi:10.1371/journal.pone.0018676.g007
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Cells were harvested and protein was extracted using cell lysis
buffer supplemented with 0.3% PMSF and proteinase and
phosphatase inhibitors. 100 mg of protein from each sample was
size fractionated on 10% SDS PAGE gels or 4–12% NATIVE
PAGE gel (Invitrogen) and transferred to PVDF membrane. The
membrane was blocked with 5% skim milk or 3% BSA with
antibodies directed at phospho-groups, and probed with an
antibody directed against either procollagen (1:200), b-actin
(1:1000), phospho-ERK1/2 (1:1000), phospho-p38 MAPK
(1:1000), phospho-AKT (1:1000), total p38 MAPK (1:1000), total
AKT, or total ERK1/2 (1:1000). The membrane was washed with
TBS-Tween and incubated with a secondary antibody, goat-anti-
rabbit-HRP (1:2000) (Jackson Labs, West Grove, PA). The signal
was developed with SuperSignal Chemiluminescent Substrate
(Pierce, Rockford, IL). The bands were assessed by densitometry
by Image J software (NIH).
In vitro Scratch Assay
Wound healing assays were performed as previously described
[9]. Confluent fibroblasts cultured on native collagen or 3DG-
collagen were pretreated with 10 mM of SB202190, 25 mMo f
LY294002, 50 mM of PD98059, or the vehicle DMSO for 1 h.
Scratch wounds were introduced with a sterile pipette tip onto the
confluent monolayer of fibroblasts. The cells were washed to
remove damaged and detached cells and DMEM containing 1%
FBS was added to prevent proliferation. At the time of wounding,
inhibitors were added back into the media containing 1% FBS.
The wound area was photographed immediately after wound
induction (0 h), and again at 24 h and 48 h post scratch using
brightfield exposure at 10 X magnification on a Nikon eclipse 80i
epi-fluorescence microscope. The images were captured using an
RT3 Color Mosaic Camera (Diagnostic Instruments, Sterling
Heights, MI). The distance between the edges of the wound were
measured at ten different areas from the wound edge to edge using
Spot software. The measurements were then converted into a
percentage using the formula: % of wound remaining =
(measurement at time X/measurement at time 0 h) * 100; then
to obtain the % of wound closure: 100% - % of wound remaining.
Immunofluorescence of Filopodia
For F-actin staining of filopodia extension, fibroblasts were
wounded as described above, washed three times with sterile PBS,
and air-dried at 4 h post scratch. The fibroblasts were then fixed
with 4% paraformaldehyde, permeabilized with 0.3% Triton X-
100, and stained with rhodamine phalloidin (Cytoskeleton,
Denver, CO). The samples were counterstained with DAPI
(Vector Laboratories, Burlingame, CA). Five images from each
sample were captured as described above at 20 X and 40 X
magnification.
Proliferation Assay
Cells were plated at a density of 4610
3 cells/well on a native
collagen or 3DG-collagen coated 96-well plate in 100 mLo f
complete DMEM supplemented with 10% FBS and 1% Penn/
Strep. Proliferation of cells was measured at 0 h, 24 h, and 48 h.
Proliferation was measured by the addition of Cell Proliferation
Reagent WST-1 to cells for 4 h at 37uC. Absorbance of the
samples was measured at 450 nm with a reference wavelength of
600 nm according to the manufacturer (Roche, Indianapolis, IN).
Caspase-3 Assay
Cells were harvested and lysed in cell lysis buffer as previously
described above. Whole cell lysates were combined with Caspase-3
substrate reaction buffer and incubated for 3 h at 37uC and the
absorbance was measured at 405 nm with a plate reader
according to the manufacturer (Assay Designs, Ann Arbor, MI).
Background readings from cell buffers and substrates were
subtracted from the sample readings according to the protocol.
Statistical Analysis
The data are presented as mean 6 SD. The resulting data were
subjected to either a two-tailed unpaired Student t- test for
comparison between two groups, or a one-way ANOVA for
comparison between multiple groups followed by Tukey’s post-hoc
test with GraphPad InStat 3 software (San Diego, CA). P values
,0.05 were considered significant.
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